Dose relativity of sevelamer hydrochloride and lanthanum carbonate under real-world conditions- Implications for management of patients with end-stage renal disease and hyperphosphatemia
May 1, 2013, 00:00 AM
10.1016/j.jval.2013.03.967
https://www.valueinhealthjournal.com/article/S1098-3015(13)01038-3/fulltext
Section Title :
Health Services
Section Order :
526
First Page :
A192
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)01038-3&doi=10.1016/j.jval.2013.03.967